A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B
Clinical trial NCT05828745 · COMPLETED
Trial details
- NCT number
- NCT05828745
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2025-02-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.